|
Dr. Peter Kiener D.Phil was promoted to senior vice president research in February 2005 with oversight of the company’s global research activities. He joined MedImmune Inc. in 2001 and was named vice president research in 2003. His scientific areas of expertise include immunology cellular and molecular biology biochemistry and high-throughput screening assays and in vivo studies. Prior to joining MedImmune Dr. Kiener spent 18 years with Bristol-Myers Squibb’s (BMS) Pharmaceutical Research Division finally holding the position of director immunology inflammation pulmonary and oncology drug discovery at the BMS facility in Princeton NJ. Before his employment at Bristol-Myers Dr. Kiener previously served as assistant professor at the University of North Texas/Texas College of Osteopathic Medicine’s Department of Anatomy; as a research associate at the Department of Biochemistry University of Massachusetts (Amherst); and as a postdoctoral research assistant Medical Research Council Sir William Dunn School of Pathology University of Oxford. Dr. Kiener holds a bachelor of science degree with honors in chemistry from Lancaster University Lancaster UK and a doctorate of philosophy in biochemistry from the Sir William Dunn School of Pathology Oxford University Oxford UK.
| 